Abstract
Emergence of human immunodeficiency virus type 1 (HIV-1) drug resistance arises from mutation fixation in the viral genome during antiretroviral therapy. Primary mutations directly confer antiviral drug resistance, while secondary mutations arise that do not confer drug resistance. The A62V amino acid substitution in HIV-1 reverse transcriptase (RT) was observed to be associated with multi-drug resistance, but is not known to be a resistance-conferring mutation. In particular, A62V was observed in various multi-dideoxynucleoside resistant (MDR) mutation complexes, including the Q151M complex (i.e., A62V, V75I, F77L, F116Y, and Q151M), and the T69SSS insertion complex, which has a serine⁻serine insertion between amino acid positions 69 and 70 (i.e., M41L, A62V, T69SSS, K70R, and T215Y). However, what selective advantage is conferred to the virus remains unresolved. In this study, we hypothesized that A62V could influence replication fidelity and viral fitness with viruses harboring the Q151M and T69SSS MDR mutation complexes. A single-cycle replication assay and a dual-competition fitness assay were used to assess viral mutant frequency and viral fitness, respectively. A62V was found to increase the observed lower mutant frequen...Continue Reading
References
Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·T ShirasakaR Yarchoan
Aug 1, 1995·Journal of Virology·L M Mansky, H M Temin
Oct 6, 1995·The Journal of Biological Chemistry·T UenoH Mitsuya
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·O BoussifJ P Behr
Jan 27, 1995·Science·J M Coffin
Apr 1, 1994·The Journal of Infectious Diseases·R W ShaferR Coombs
Feb 1, 1996·Journal of Virology·A K IversenT C Merigan
Jun 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E DomingoJ J Holland
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·A GervaixJ Corbeil
Jun 23, 1997·Virology·M A VodickaM Emerman
May 21, 1998·The Journal of Infectious Diseases·Y MaedaH Mitsuya
Nov 11, 1998·JAMA : the Journal of the American Medical Association·R DetelsJ P Phair
Nov 30, 1998·Science·H HuangS C Harrison
Jun 11, 1999·Journal of Virology·P KosalaraksaH Mitsuya
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Oct 3, 2000·Advances in Pharmacology·F ClavelF Mammano
Nov 4, 2000·The EMBO Journal·A MasL Menéndez-Arias
Nov 15, 2000·Cellular and Molecular Life Sciences : CMLS·N Sluis-CremerM A Parniak
Jul 4, 2001·Annals of Internal Medicine·E L MurphyUNKNOWN Viral Activation Transfusion Study Investigators
Jan 31, 2002·Annual Review of Medicine·Joel N BlanksonRobert F Siliciano
Sep 20, 2002·Journal of Virology·Miguel E Quiñones-MateuMiguel A Martínez
Jan 15, 2003·Journal of Virology·Deborah PersaudRobert F Siliciano
Jan 30, 2004·Journal of Virology·Haili ZhangRobert F Siliciano
Mar 30, 2004·The Journal of Biological Chemistry·Tania MatamorosLuis Menéndez-Arias
Sep 6, 2005·Journal of Virology·Renxiang ChenLouis M Mansky
May 27, 2006·Current Pharmaceutical Design·Luis Menéndez-AriasClara E Cases-González
Oct 31, 2006·Journal of Molecular Biology·Clara E Cases-GonzálezLuis Menéndez-Arias
Dec 29, 2006·Chemistry & Biodiversity·Erik De Clercq
Feb 21, 2007·The Medical Journal of Australia·Luke F ChenSharon R Lewin
Jun 5, 2007·PLoS Pathogens·Cleo G AnastassopoulouJohn P Moore
Feb 19, 2008·The Pediatric Infectious Disease Journal·Mireille HenryCatherine Tamalet
Nov 22, 2008·Journal of Molecular Biology·Stefan G SarafianosEddy Arnold
Feb 3, 2011·The Journal of Infectious Diseases·Alexandra U ScherrerUNKNOWN Swiss HIV Cohort Study
Oct 23, 2012·Journal of Molecular Biology·Michael J DappLouis M Mansky
Dec 4, 2012·Journal of Virological Methods·Yi LiuJames I Mullins
Oct 15, 2013·Bioorganic & Medicinal Chemistry·Jonathan M RawsonLouis M Mansky
Oct 25, 2013·Journal of Virology·Michael J DappLouis M Mansky
Dec 31, 2015·Methods in Molecular Biology·Jonathan M O RawsonLouis M Mansky